Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms.

[1]  A. Verdeguer,et al.  Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  J. Kanda,et al.  Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia , 2013, Haematologica.

[3]  J. Wagner,et al.  Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. , 2013, Blood.

[4]  C. Solano,et al.  Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen , 2012, Bone Marrow Transplantation.

[5]  Colleen Delaney,et al.  Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. , 2010, Blood.

[6]  J. Wagner,et al.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. , 2010, The Lancet. Oncology.

[7]  E. Gluckman,et al.  Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases. , 2010, Best practice & research. Clinical haematology.

[8]  J. Perkins,et al.  Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease , 2010, Bone Marrow Transplantation.

[9]  J. Wagner,et al.  Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. , 2009, Blood.

[10]  M. Sanz,et al.  Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  J. Wagner,et al.  Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. , 2009, Blood.

[12]  J. Wagner,et al.  Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Wagner,et al.  Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. , 2007, Blood.

[14]  C. Walker,et al.  Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  J. Klein,et al.  Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study , 2007, The Lancet.

[16]  Todd E DeFor,et al.  Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. , 2005, Blood.

[17]  K. Cornetta,et al.  Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  M. Labopin,et al.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. , 2004, The New England journal of medicine.

[19]  J. Wagner,et al.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.

[20]  S. Chevret,et al.  Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. , 2004, Experimental hematology.

[21]  J Wagner,et al.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.

[22]  P. Bolufer,et al.  Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. , 2001, Blood.

[23]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[24]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[25]  J. Adamson,et al.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.

[26]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[27]  K. Sullivan,et al.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.

[28]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[29]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[30]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[31]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[32]  L. Freedman,et al.  Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries , 2011, Bone Marrow Transplantation.

[33]  M. Shimoyama,et al.  Delayed neutrophil engraftment in cord blood transplantation with intensive administration of mycophenolate mofetil for GVHD prophylaxis , 2011, Bone Marrow Transplantation.

[34]  M. Sanz,et al.  Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[35]  P. Wernet,et al.  Unrelated cord blood transplants in adults with hematologic malignancies. , 2006, Haematologica.

[36]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[37]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .